CIK 0001980845 · <br>Emerging growth company
enGene Therapeutics Inc.
Sign in to watch- Ticker
- ENGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Oct 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (514) 332-4888
- Business address
- 4868 RUE LEVY, SUITE 220, SAINT-LAURENT, Quebec, Canada
- Former names
- enGene Holdings Inc.
Securities
- ENGN Common Stock Nasdaq
- ENGNW Warrants Nasdaq
- Open-market buys, last 90 days
- $10,051
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$10,051. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-21 | Connolly Joan Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +210,000 | 210,000 | ||
| 2024-10-08 | Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner | Purchase | +800 | $6.60 | $5K | 2,470,633 |
| 2024-10-07 | Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner | Purchase | +11,844 | $6.55 | $78K | 2,469,833 |
| 2024-10-04 | Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner | Purchase | +5,997 | $6.54 | $39K | 2,457,989 |
| 2024-10-03 | Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner | Purchase | +5,769 | $6.48 | $37K | 2,451,992 |
| 2024-10-02 | Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner | Purchase | +10,153 | $6.37 | $65K | 2,446,223 |
| 2024-10-01 | Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner | Purchase | +35,279 | $6.44 | $227K | 2,436,070 |
| 2024-09-30 | Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner | Purchase | +341,332 | $6.34 | $2.2M | 2,400,791 |
| 2024-09-27 | Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner | Purchase | +38,396 | $5.94 | $228K | 2,056,216 |
| 2024-09-27 | Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner | Purchase | +3,243 | $6.38 | $21K | 2,059,459 |
| 2024-09-27 | Cooper Ronald Harold Wilfred Chief Executive Officer | Purchase | +10,000 | $5.70 | $57K | 10,000 |
| 2024-07-24 | Pruthi Raj Som Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +110,000 | 110,000 | ||
| 2024-07-22 | Cooper Ronald Harold Wilfred Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,250,000 | 1,250,000 | ||
| 2024-06-15 | Zoth Lota S. Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2024-06-15 | HASTINGS PAUL J Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2024-06-15 | Joustra Wouter Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2024-06-15 | Glickman Richard M Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2024-06-15 | Bos Jasper Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2024-06-15 | BRUNK GERALD A Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2024-05-28 | Glickman Richard M Director | Option exercise | +120 | $0.89 | $107 | 24,675 |
Page 3 of 7 · 121 trades